{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:51:49Z","timestamp":1793242309094,"version":"4.5.0"},"reference-count":78,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of extranodal non-Hodgkin\u2019s lymphomas that are characterized by a cutaneous infiltration of malignant monoclonal T lymphocytes. They typically afflict adults with a median age of 55 to 60 years, and the annual incidence is about 0.5 per 100,000. Mycosis fungoides, S\u00e9zary syndrome, and primary cutaneous peripheral T cell lymphomas not otherwise specified are the most important subtypes of CTCL. CTCL is a complicated concept in terms of etiopathogenesis, diagnosis, therapy, and prognosis. Herein, we summarize advances which have been achieved in these fields.<\/ns4:p>","DOI":"10.12688\/f1000research.8829.1","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T07:30:07Z","timestamp":1469691007000},"page":"1882","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":89,"title":["An overview of cutaneous T cell lymphomas"],"prefix":"10.12688","volume":"5","author":[{"given":"Nooshin","family":"Bagherani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Smoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1-10","DOI":"10.1155\/2012\/290685","article-title":"Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors.","volume":"2012","author":"A Rodd","year":"2012","journal-title":"Lymphoma."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"e970025","DOI":"10.4161\/21624011.2014.970025","article-title":"Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma.","volume":"3","author":"I Litvinov","year":"2014","journal-title":"Oncoimmunology."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"15235-49","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin \u03b1 and drive endothelial activation in cutaneous T cell lymphoma.","volume":"6","author":"B Lauenborg","year":"2015","journal-title":"Oncotarget."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4103\/0019-5154.156423","article-title":"Evaluation of the Association Between Epstein-Barr Virus and Mycosis Fungoides.","volume":"60","author":"Y Nahidi","year":"2015","journal-title":"Indian J Dermatol."},{"key":"ref-5","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2015.3831\/2015","article-title":"Unusual involvement in mycosis fungoides: Duodenal papilla.","author":"A G\u00f3mez Venegas","year":"2015","journal-title":"Rev Esp Enferm Dig."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"225-37","DOI":"10.1007\/s40257-016-0177-5","article-title":"Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.","volume":"17","author":"S Devata","year":"2016","journal-title":"Am J Clin Dermatol."},{"key":"ref-7","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2362","article-title":"Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma.","author":"L V\u00e4kev\u00e4","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"ref-8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/429068","article-title":"Primary Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified: A Rapidly Progressive Variant of Cutaneous T-Cell Lymphoma.","volume":"2015","author":"K Aderhold","year":"2015","journal-title":"Case Rep Oncol Med."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"669-73","DOI":"10.2340\/00015555-2337","article-title":"Mycosis Fungoides: A Retrospective Study of 44 Swedish Cases.","volume":"96","author":"Y Eklund","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"437-42","DOI":"10.5114\/pdia.2015.48034","article-title":"Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides.","volume":"32","author":"J Maj","year":"2015","journal-title":"Postepy Dermatol Alergol."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"e0146115","DOI":"10.1371\/journal.pone.0146115","article-title":"The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides\/Sezary Syndrome Alone or with Doxorubicin.","volume":"11","author":"L Moyal","year":"2016","journal-title":"PLoS One."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"1011-9","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma.","volume":"47","author":"J Choi","year":"2015","journal-title":"Nat Genet."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"31868-76","DOI":"10.18632\/oncotarget.5573","article-title":"EPHA4 is overexpressed but not functionally active in S\u00e9zary syndrome.","volume":"6","author":"L Hameetman","year":"2015","journal-title":"Oncotarget."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"E131-9","DOI":"10.1188\/15.CJON.E131-E139","article-title":"Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.","volume":"19","author":"A Benjamin Chase","year":"2015","journal-title":"Clin J Oncol Nurs."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"901-4","DOI":"10.1111\/bjd.14238","article-title":"Unmasking mycosis fungoides\/S\u00e9zary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course.","volume":"174","author":"S Foo","year":"2016","journal-title":"Br J Dermatol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"37-41","DOI":"10.15570\/actaapa.2015.10","article-title":"Poikilodermatous mycosis fungoides: clinical and histopathological analysis of a case and literature review.","volume":"24","author":"O Pankratov","year":"2015","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"745-54","DOI":"10.1097\/PAS.0000000000000596","article-title":"Useful Parameters for Distinguishing Subcutaneous Panniculitis-like T-Cell Lymphoma From Lupus Erythematosus Panniculitis.","volume":"40","author":"R LeBlanc","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"ref-18","doi-asserted-by":"crossref","first-page":"1423-30","DOI":"10.1097\/00000478-199512000-00009","article-title":"Reassessment of histologic parameters in the diagnosis of mycosis fungoides.","volume":"19","author":"B Smoller","year":"1995","journal-title":"Am J Surg Pathol."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"541-5","DOI":"10.1097\/DAD.0000000000000493","article-title":"Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient.","volume":"38","author":"N Kash","year":"2016","journal-title":"Am J Dermatopathol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"35-9","DOI":"10.1111\/j.1600-0560.2008.01120.x","article-title":"Mycosis fungoides: what do\/do not we know?","volume":"35","author":"B Smoller","year":"2008","journal-title":"J Cutan Pathol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"287-91","DOI":"10.1159\/000440856","article-title":"Koebner Phenomenon and Mycosis Fungoides.","volume":"7","author":"E Lebas","year":"2015","journal-title":"Case Rep Dermatol."},{"key":"ref-22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5742","article-title":"Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma.","author":"B Dulmage","year":"2015","journal-title":"Oncotarget."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"1426-34","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of S\u00e9zary syndrome identifies alterations of key T cell signaling and differentiation genes.","volume":"47","author":"L Wang","year":"2015","journal-title":"Nat Genet."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1465-70","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome.","volume":"47","author":"A da Silva Almeida","year":"2015","journal-title":"Nat Genet."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"20555-69","DOI":"10.18632\/oncotarget.4111","article-title":"Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.","volume":"6","author":"N Sibbesen","year":"2015","journal-title":"Oncotarget."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"1238-46","DOI":"10.1016\/j.jid.2016.01.028","article-title":"Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.","volume":"136","author":"W Woollard","year":"2016","journal-title":"J Invest Dermatol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"5359-64","DOI":"10.7314\/APJCP.2015.16.13.5359","article-title":"Expression of Granulysin and FOXP3 in Cutaneous T Cell Lymphoma and S\u00e9zary Syndrome.","volume":"16","author":"M Shareef","year":"2015","journal-title":"Asian Pac J Cancer Prev."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"508-19","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides.","volume":"126","author":"L McGirt","year":"2015","journal-title":"Blood."},{"key":"ref-29","doi-asserted-by":"crossref","first-page":"189-97","DOI":"10.21873\/anticanres.11006","article-title":"Expression of SATB1, MTI\/II and Ki-67 in Mycosis Fungoides.","volume":"36","author":"A Jankowska-Konsur","year":"2016","journal-title":"Anticancer Res."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1056-60","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and S\u00e9zary  syndrome identifies recurrent alterations in TNFR2.","volume":"47","author":"A Ungewickell","year":"2015","journal-title":"Nat Genet."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"3144-52","DOI":"10.1038\/jid.2015.328","article-title":"Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides.","volume":"135","author":"F Gallardo","year":"2015","journal-title":"J Invest Dermatol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"2153-4","DOI":"10.1038\/jid.2015.221","article-title":"PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.","volume":"135","author":"C Tensen","year":"2015","journal-title":"J Invest Dermatol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"3692-704","DOI":"10.1038\/onc.2015.435","article-title":"MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.","volume":"35","author":"A Kitadate","year":"2016","journal-title":"Oncogene."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"555-60","DOI":"10.1097\/DAD.0b013e318276cc68","article-title":"Expression of PTEN in mycosis fungoides and correlation with loss of heterozygosity.","volume":"35","author":"T Katona","year":"2013","journal-title":"Am J Dermatopathol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"1552-6","DOI":"10.1097\/PAS.0b013e3180408d76","article-title":"Loss of heterozygosity analysis identifies genetic abnormalities in mycosis fungoides and specific loci associated with disease progression.","volume":"31","author":"T Katona","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"819-22","DOI":"10.1111\/1346-8138.13278","article-title":"Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoides.","volume":"43","author":"M Kabasawa","year":"2016","journal-title":"J Dermatol."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"3328-39","DOI":"10.1158\/1078-0432.CCR-15-1784","article-title":"STAT3\/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.","volume":"22","author":"P Vieyra-Garcia","year":"2016","journal-title":"Clin Cancer Res."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"13563-74","DOI":"10.18632\/oncotarget.6916","article-title":"Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.","volume":"7","author":"S Ikeda","year":"2016","journal-title":"Oncotarget."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"464-7","DOI":"10.2340\/00015555-2264","article-title":"Expression of CD164 on Malignant T cells in S\u00e9zary Syndrome.","volume":"96","author":"E Guenova","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"354-62","DOI":"10.1182\/blood-2015-02-628149","article-title":"Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.","volume":"126","author":"S Jain","year":"2015","journal-title":"Blood."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"554-6","DOI":"10.1590\/abd1806-4841.20153460","article-title":"Granulomatous mycosis fungoides--a diagnostic challenge.","volume":"90","author":"C Pousa","year":"2015","journal-title":"An Bras Dermatol."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1287-96","DOI":"10.1182\/blood-2015-08-662353","article-title":"Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.","volume":"127","author":"A Willerslev-Olsen","year":"2016","journal-title":"Blood."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"1003-10","DOI":"10.1136\/jclinpath-2015-203133","article-title":"Primary cutaneous T-cell lymphomas: a review.","volume":"68","author":"K Sidiropoulos","year":"2015","journal-title":"J Clin Pathol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"308-158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL.","volume":"7","author":"I Kirsch","year":"2015","journal-title":"Sci Transl Med."},{"key":"ref-45","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12349","article-title":"Mycosis fungoides and S\u00e9zary syndrome: Current challenges in assessment, management and prognostic markers.","author":"C Hughes","year":"2015","journal-title":"Australas J Dermatol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"199-203","DOI":"10.4103\/0972-3919.158527","article-title":"The role of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with mycosis fungoides.","volume":"30","author":"E Alanteri","year":"2015","journal-title":"Indian J Nucl Med."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"870-7","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u03b2 chain restriction.","volume":"74","author":"J Gibson","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"A438","DOI":"10.1016\/j.jval.2015.09.1065","article-title":"Systematic Review Of Burden Of Cutaneous T-Cell Lymphoma.","volume":"18","author":"S Aggarwal","year":"2015","journal-title":"Value Health."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"183-6","DOI":"10.1016\/j.prro.2015.10.021","article-title":"Adaptation of the Stanford technique for treatment of bulky cutaneous T-cell lymphoma of the head.","volume":"6","author":"S Ahmed","year":"2016","journal-title":"Pract Radiat Oncol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"67-72","DOI":"10.5114\/pdia.2014.40941","article-title":"Follow-up of patients with mycosis fungoides after interferon \u03b12b treatment failure.","volume":"32","author":"E Chmielowska","year":"2015","journal-title":"Postepy Dermatol Alergol."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"3766-73","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and S\u00e9zary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.","volume":"33","author":"J Scarisbrick","year":"2015","journal-title":"J Clin Oncol."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"151-65","DOI":"10.1002\/ajh.24233","article-title":"Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.","volume":"91","author":"R Wilcox","year":"2016","journal-title":"Am J Hematol."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"807-18","DOI":"10.1016\/j.det.2015.05.014","article-title":"Hematopoietic Stem Cell Transplant for Mycosis Fungoides and S\u00e9zary Syndrome.","volume":"33","author":"P Virmani","year":"2015","journal-title":"Dermatol Clin."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"1452-61","DOI":"10.1182\/blood-2015-02-630335","article-title":"Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.","volume":"126","author":"A Rook","year":"2015","journal-title":"Blood."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"683-96","DOI":"10.1016\/j.det.2015.05.004","article-title":"Skin-Directed Therapies in Cutaneous T-Cell Lymphoma.","volume":"33","author":"C Nguyen","year":"2015","journal-title":"Dermatol Clin."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"17-25","DOI":"10.1016\/j.jdermsci.2015.10.016","article-title":"Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptor\u03b22, via histone acetylation.","volume":"81","author":"Y Kato","year":"2016","journal-title":"J Dermatol Sci."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"715-29","DOI":"10.1016\/j.det.2015.05.007","article-title":"The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma.","volume":"33","author":"A Huen","year":"2015","journal-title":"Dermatol Clin."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"228-40","DOI":"10.1016\/j.critrevonc.2015.12.018","article-title":"Panoptic clinical review of the current and future treatment of relapsed\/refractory T-cell lymphomas: Cutaneous T-cell lymphomas.","volume":"99","author":"P Zinzani","year":"2016","journal-title":"Crit Rev Oncol Hematol."},{"key":"ref-59","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/254560","article-title":"Identification of Bexarotene as a PPAR\u03b3 Antagonist with HDX.","volume":"2015","author":"D Marciano","year":"2015","journal-title":"PPAR Res."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"117-20","DOI":"10.1016\/j.medcli.2015.07.017","article-title":"[Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma].","volume":"146","author":"S Rodriguez Suarez","year":"2016","journal-title":"Med Clin (Barc)."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"244-8","DOI":"10.1177\/1203475415626686","article-title":"Tazarotene 0.1% Cream as Monotherapy for Early-Stage Cutaneous T-Cell Lymphoma.","volume":"20","author":"C Besner Morin","year":"2016","journal-title":"J Cutan Med Surg."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"468-76","DOI":"10.1007\/s11899-015-0293-y","article-title":"Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy.","volume":"10","author":"C Chung","year":"2015","journal-title":"Curr Hematol Malig Rep."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1038\/bcj.2015.83","article-title":"Romidepsin targets multiple survival signaling pathways in malignant T cells.","volume":"5","author":"B Valdez","year":"2015","journal-title":"Blood Cancer J."},{"key":"ref-64","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14427","article-title":"Phase II Multicenter Trial of Oral Quisinostat, a Histone Deacetylase Inhibitor, in Patients with Previously Treated Stage IB-IVA Mycosis Fungoides\/S\u00e9zary Syndrome.","author":"F Child","year":"2016","journal-title":"Br J Dermatol."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"27-58","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.","volume":"74","author":"E Olsen","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"703-13","DOI":"10.1016\/j.det.2015.05.006","article-title":"Radiation Therapy for Cutaneous T-Cell Lymphomas.","volume":"33","author":"D Tandberg","year":"2015","journal-title":"Dermatol Clin."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"1354-7","DOI":"10.1001\/jamadermatol.2015.3028","article-title":"Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy.","volume":"151","author":"A Goddard","year":"2015","journal-title":"JAMA Dermatol."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"1077-86","DOI":"10.1016\/j.ijrobp.2015.08.041","article-title":"Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.","volume":"93","author":"K Elsayad","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"ref-69","first-page":"1124-31","article-title":"Evaluation of mycosis fungoides management by total skin electron beam therapy with \"translational technique\".","volume":"20","author":"H Gamsiz","year":"2015","journal-title":"J BUON."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"1444-51","DOI":"10.1111\/php.12521","article-title":"Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma.","volume":"91","author":"K Salva","year":"2015","journal-title":"Photochem Photobiol."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"765-76","DOI":"10.1016\/j.det.2015.05.011","article-title":"Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and S\u00e9zary Syndrome.","volume":"33","author":"J Zic","year":"2015","journal-title":"Dermatol Clin."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"638-42","DOI":"10.1111\/1346-8138.13199","article-title":"Hematopoietic stem cell transplantation for cutaneous T-cell lymphoma: Summary of 11 cases from two facilities in Japan and Brazil.","volume":"43","author":"T Oka","year":"2016","journal-title":"J Dermatol."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"2490-5","DOI":"10.1093\/annonc\/mdv473","article-title":"Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.","volume":"26","author":"C Hosing","year":"2015","journal-title":"Ann Oncol."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"328-35","DOI":"10.1182\/blood-2015-02-629543","article-title":"The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma.","volume":"126","author":"T Witzig","year":"2015","journal-title":"Blood."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"166-71","DOI":"10.1097\/CCO.0000000000000272","article-title":"Experimental treatment strategies in primary cutaneous T-cell lymphomas.","volume":"28","author":"S Rozati","year":"2016","journal-title":"Curr Opin Oncol."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"49-56","DOI":"10.1016\/j.clml.2015.11.010","article-title":"Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.","volume":"16","author":"R Talpur","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"ref-77","first-page":"6017-26","article-title":"Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.","volume":"35","author":"A Jankowska-Konsur","year":"2015","journal-title":"Anticancer Res."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"535-9","DOI":"10.2340\/00015555-2283","article-title":"Cutaneous Lymphoma in Korea: A Nationwide Retrospective Study.","volume":"96","author":"H Lee","year":"2016","journal-title":"Acta Derm Venereol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/5-1882\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-1882\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-1882\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T11:36:03Z","timestamp":1553254563000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/5-1882\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":78,"URL":"https:\/\/doi.org\/10.12688\/f1000research.8829.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.9504.r14988","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.9504.r14987","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/5-1882\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.9504.r14987, Mary Jo Lechowicz, Department of Hematology Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA, 28 Jul 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-1882\/v1#referee-response-14987","order":0,"name":"referee-response-14987","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.9504.r14988, Stefano A. Pileri, Unit of Haematopathology, European Institute of Oncology, Milan\/Bologna University School of Medicine, Bologna, Italy, 28 Jul 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-1882\/v1#referee-response-14988","order":1,"name":"referee-response-14988","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}